Bayer Schering Pharma: Innovating the Future of Global Healthcare
Bayer Schering Pharma, now a division of Bayer AG, emerged after Bayer acquired Schering AG in 2006. It focuses on oncology, cardiology, women’s healthcare, and specialty medicine. This merger combined Schering’s biotechnology expertise with Bayer’s research strengths, facilitating advancements in drug development. The division prioritizes innovation, research, and sustainable practices, aligning with global demands for eco-friendly pharmaceutical solutions.

